drugset / Trial / NCT03789318
Study in Subjects Undergoing Complete Abdominoplasty
RandomizedParallel-groupTriple-blindTreatment
Summary
Phase 2, single center, randomized, double-blind, placebo-controlled, parallel design study of CA-008 vs. placebo in subjects undergoing an elective C-ABD under general anesthesia supplemented with a bupivacaine hydrochloride (HCl)transverse abdominis plane (TAP) block.
Timeline
- Start
- 2018-12-03
- Primary completion
- 2019-05-16
- Completion
- 2019-06-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | vocacapsaicin | Small molecule | 5 mg | Other |
| Comparator | vocacapsaicin | Small molecule | 10 mg | Other |
| Comparator | vocacapsaicin | Small molecule | 15 mg | Other |
| Comparator | Acetaminophen | Small molecule | 1000 mg | Intravenous |
| Comparator | Bupivacaine | Other / unclassified | 150 mg | Other |
| Comparator | Fentanyl | Other / unclassified | 100 ug | Intravenous |
| Comparator | Hydromorphone | Other / unclassified | 0.02 mg/kg | Intravenous |
| Comparator | Oxycodone | Other / unclassified | 5 mg | Oral |
| Comparator | Oxycodone | Other / unclassified | 10 mg | Oral |
Indications
No indication recorded.